# Catriona M. McNeil

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/catriona-m-mcneil/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,643 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 44 |
| i10-index | 79 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5055983682 |
| ORCID iD | https://orcid.org/0000-0002-3732-766X |
| Works | 184 |

## Researcher papers

- [Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial](https://scholariq.org/papers/adjuvant-vemurafenib-in-resected-brafv600-mutation-positive-melanoma-brim8-a/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.